InfuSystem Holdings (INFU) Cash from Financing Activities (2010 - 2026)

InfuSystem Holdings (INFU) reported Cash from Financing Activities of -$790000.0 for Q1 2026, down 142.47% on a YoY basis from $1.9 million in Q1 2025, and up 70.77% quarter-over-quarter from -$2.7 million in Q4 2025.

InfuSystem Holdings (INFU) Cash from Financing Activities (2010 - 2026) Analysis & Trends

InfuSystem Holdings has reported Cash from Financing Activities for 17 years, with the latest figure at -$790000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 142.47% year-over-year to -$790000.0; the trailing twelve-month figure through Mar 2026 stood at -$17.6 million (down 209.15% YoY), and the FY2025 full-year result was -$15.0 million, down 116.05% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$790000.0, up from -$2.7 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $3.7 million in Q2 2024, with the low at -$8.0 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged -$2.0 million across 5 years, with a median of -$1.7 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 4117.35% — and 2024, when it surged 1679.15%.
  • InfuSystem Holdings' Cash from Financing Activities stood at -$1.7 million in 2022, then tumbled by 107.01% to -$3.5 million in 2023, then slipped by 27.4% to -$4.5 million in 2024, then soared by 40.13% to -$2.7 million in 2025, then soared by 70.77% to -$790000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$790000.0 (Q1 2026), -$2.7 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 InfuSystem Holdings 189.78 Mn 187.68 Mn 19.68 Mn -790,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -790,000.00
Mar 31, 2026 -790,000.00
Dec 31, 2025 -2.70 Mn
Dec 31, 2025 -2.70 Mn
Sep 30, 2025 -8.01 Mn
Sep 30, 2025 -8.01 Mn
Jun 30, 2025 -6.11 Mn
Jun 30, 2025 -6.11 Mn
Mar 31, 2025 1.86 Mn
Mar 31, 2025 1.86 Mn
Dec 31, 2024 -4.52 Mn
Dec 31, 2024 -4.52 Mn
Sep 30, 2024 -6.75 Mn
Sep 30, 2024 -6.75 Mn
Jun 30, 2024 3.71 Mn
Jun 30, 2024 3.71 Mn
Mar 31, 2024 632,000.00
Mar 31, 2024 632,000.00
Dec 31, 2023 -3.54 Mn
Dec 31, 2023 -3.54 Mn